| Biochemistry |
| Paul Brindle, PhD |
Gene regulation by transcriptional coactivators |
| James N. Ihle, PhD (Dept Chair) |
Cytokine binding, signaling, and cellular responses |
| Leta K. Nutt, PhD |
Metabolic regulation of cancer cell death |
| Stacey K. Ogden, PhD |
Mechanisms of Hedgehog signal transduction |
| Joseph T. Opferman, PhD |
Regulation of cell death during hematopoiesis |
| Janet F. Partridge, PhD |
Chromosome segregation, heterochromatin assembly |
| Gerard P. Zambetti, PhD |
p53 function in tumor suppression and tumorigenesis |
| Biostatistics |
| James M. Boyett, PhD (Dept. Chair) |
Statistical design and analysis of clinical trials |
| Cheng Cheng, PhD |
Statistical methods in cancer genomics and genetics |
| Guolian Kang, PhD |
Statistical genetics and genomics, modeling of complex data |
| Yimei Li, PhD |
Statistical analysis of complex imaging data |
| Shaoyu Li, PhD |
Statistical genetics and genomics, applications in biological sciences |
| Arzu Onar-Thomas, PhD |
Phase I-II designs, survival analysis, Bayesian statistics |
| Stanley B. Pounds, PhD |
Development of statistical methods for genomics studies |
| Deo Kumar Srivastava, PhD |
Clinical trials, robust methods, survival analysis |
| Jianrong (John) Wu, PhD |
Design and analysis of preclinical and clinical trials |
| Hui Zhang, PhD |
Statistical methods for psychological research |
| Liang Zhu, PhD |
Survival analysis and longitudinal data analysis |
| Bone Marrow Transplant & Cellular Therapy |
| Mari H. Dallas, MD |
Cord blood transplantation and immune reconstitution |
| Wing H. Leung, MD, PhD |
NK cell and stem cell transplantation, late effects |
| Asha Pillai, MD |
Immunobiology of alloregulation, engraftment, and GVHD |
| Chemical Biology & Therapeutics |
| Taosheng Chen, PhD |
Small-molecule transcription factor drug discovery |
| Naoaki Fujii, PhD |
Medicinal chemistry, chemical biology, PDZ domain |
| R. Kiplin Guy, PhD (Dept Chair) |
Chemical biology and orphan disease drug discovery |
| Richard Lee, PhD |
Development of new chemotherapeutic agents |
| Philip M. Potter, PhD |
Anticancer drug hydrolysis by carboxylesterases |
| Fatima Rivas, PhD |
Organic chemistry synthesis/natural product discovery |
| Anang Shelat, PhD |
Multi-scale modeling of biological and chemical data |
| Michael Taylor, PhD |
Blood-brain barrier development and function |
| Thomas R. Webb, PhD |
Synthetic organic chemistry-based drug discovery |
| Computational Biology |
| Junghui Zhang, PhD |
Computational biology, genetic alterations in cancer |
| Developmental Neurobiology |
| Suzanne J. Baker, PhD |
PTEN and key signaling pathways in brain tumors |
| Xinwei Cao, PhD |
Growth control during neural tube development |
| Fabio Demontis, PhD |
Mechanisms of muscle aging, proteostasis, and myokine signaling |
| Michael A. Dyer, PhD |
Retinal development and retinoblastoma |
| Richard J. Gilbertson, MD, PhD |
The cellular and molecular origins of brain tumors |
| Young Goo Han, PhD |
Primary cilia in brain development and tumorigenesis |
| Myriam Labelle, PhD |
Role of platelets in cancer metastasis |
| James I. Morgan, PhD (Dept Chair) |
Control of neuronal death and differentiation |
| Jamy Peng, PhD |
Epigenetic regulation of stem cell identity and functions |
| Richard J. Smeyne, PhD |
Role of viruses, inflammation, and oxidative stress in neurodegeneration |
| David J. Solecki, PhD |
Cell polarity in neuron precursor differentiation |
| J. Paul Taylor, MD, PhD |
Molecular genetics of neurological diseases |
| Stanislav S. Zakharenko, MD, PhD |
Learning and memory, synaptic mechanisms of schizophrenia |
| Jian Zuo, PhD |
Auditory hair cell function and regeneration in mice |
| Epidemiology & Cancer Control |
| Tara M. Brinkman, PhD |
Psychosocial outcomes of childhood cancer |
| Cheryl Cox, PhD |
Health promotion, early/late effects of treatment |
| Robert C. Klesges, PhD |
Cancer prevention and control in adults and children |
| Kevin R. Krull, PhD |
Neurocognitive outcomes of pediatric cancer |
| Kirsten K. Ness, PT, PhD |
Functional limitations among cancer survivors |
| Rohit Ojha, PhD |
Health outcomes among childhood cancer survivors |
| Leslie L. Robison, PhD (Dept Chair) |
Pediatric cancer epidemiology and outcomes |
| Genetics |
| Alessandra d’Azzo, PhD |
Intracellular degradation in development and disease |
| Gerard C. Grosveld, PhD (Dept Chair) |
The role of chromosome translocations in cancer |
| Peter J. McKinnon, PhD |
DNA damage responses in the nervous system |
| Guillermo C. Oliver, PhD |
Development of the CNS and lymphatic vasculature |
| Beatriz Sosa-Pineda, PhD |
Pancreas and liver organogenesis in mammals |
| Hematology |
| Wilson Clements, PhD |
Vascular/hematopoietic development and leukemia |
| Shannon McKinney-Freeman, PhD |
Mechanisms of hematopoietic stem cell development |
| Arthur W. Nienhuis, MD |
Genetic therapy of hematological diseases |
| Derek A. Persons, MD, PhD |
Gene therapy development for hemoglobin disorders |
| Brian P. Sorrentino, MD |
Gene therapy and hematopoietic stem cell biology |
| Immunology |
| Mark Bix, PhD |
Cytokine gene regulation in T-cell differentiation |
| Hongbo Chi, PhD |
Cellular signaling in innate and adaptive immunity |
| Peter C. Doherty, PhD |
Molecular and cellular analysis of CD8+T cells |
| Douglas R. Green, PhD (Dept Chair) |
Apoptosis, autophagy, and mitochondria |
| Thirumala-Devi Kanneganti, PhD |
Mechanisms of host defense and inflammation |
| Maureen A. McGargill, PhD |
T cell regulation to treat autoimmune diseases |
| Paul G. Thomas, PhD |
Innate and adaptive immunity to influenza |
| Dario A.A. Vignali, PhD |
Regulatory T cells and T-cell signaling |
| Infectious Diseases |
| Hans Haecker, MD, PhD |
Signal transduction of Toll-like and TNF receptors |
| Julia L. Hurwitz, PhD |
Vaccine-induced immunity |
| Suzanne Jackowski, PhD |
Phospholipids and coenzyme A in health and disease |
| Peter J. Murray, PhD |
Control of inflammatory responses |
| Charles O. Rock, PhD |
Membrane phospholipid metabolism |
| Jason W. Rosch, PhD |
Bacterial genomics and pathogenesis |
| Charles J. Russell, PhD |
Respiratory viruses: disease, cures, and prevention |
| Stacey Schultz-Cherry, PhD |
Pathogenesis of influenza virus and astrovirus |
| Elaine I. Tuomanen, MD (Dept Chair) |
Pathogenesis of pneumococcal infection |
| Richard J. Webby, PhD |
Influenza virus pathogenicity |
| Robert G. Webster, PhD |
Influenza evolution and control |
| Oncology |
| Kevin Freeman, PhD |
Genetic interactions that give rise to neuroblastoma |
| Tanja A. Gruber, MD, PhD |
Pathogenesis of infantile leukemia |
| Mark Hatley, MD, PhD |
Origins of pediatric sarcomas |
| Pathology |
| John Choi, MD, PhD |
Transcription factors in acute leukemias |
| James R. Downing, MD (Sci Director) |
The molecular pathology of acute leukemia |
| David Ellison, MD, PhD (Dept Chair) |
Pathologic and molecular characterization of CNS tumors |
| Terrence L. Geiger, MD, PhD |
T-cell regulation, autoimmunity |
| Mondira Kundu, MD, PhD |
The role of autophagy in erythroid maturation and anemia |
| Charles G. Mullighan, MD |
Genomic profiling of acute leukemia |
| Pharmaceutical Sciences |
| Sharyn D. Baker, PharmD, PhD |
Clinical pharmacology of tyrosine kinase inhibitors |
| William E. Evans, PharmD (Dir & CEO) |
Pharmacogenomics of antileukemic agents in children |
| Mary V. Relling, PharmD (Dept Chair) |
Pharmacokinetics and genetics of leukemia therapy |
| Erin G. Schuetz, PhD |
Mechanisms of human variation in drug response |
| John D. Schuetz, PhD |
Regulation and function of ABC transporters |
| Alex Sparreboom, PhD |
Interaction of cancer drugs with solute carriers |
| Clinton F. Stewart, PharmD |
Pharmacology of anticancer drugs in children |
| Jun Yang, PhD |
Pharmacogenomics of anticancer agents and drug resistance |
| Psychology |
| Heather Conklin, PhD |
Neuropsychological outcomes in childhood cancer survivors |
| Valerie Crabtree, PhD |
Sleep disruptions in children with cancer |
| Lisa M. Ingerski, PhD |
Adherence promotion and quality of life outcomes |
| James L. Klosky, PhD |
Behavior-based cancer prevention and control |
| Sean Phipps, PhD (Dept. Chair) |
Coping and adjustment in children with cancer |
| Jerlym S. Porter, PhD |
Transition from pediatric care to adult care in SCD patients; psychosocial factors in health management |
| Jane E. Schreiber, PhD |
Neurobehavioral functioning in children with medical disorders |
| Vida L. Tyc , PhD |
Tobacco control and secondhand smoke exposure |
| Radiological Sciences |
| Claudia M. Hillenbrand, PhD |
Novel MR techniques in solid tumors and sickle cell disease |
| Sue C. Kaste, DO |
Skeletal toxicities in childhood cancer survivors |
| Matthew J. Krasin, MD |
Developing radiation therapy strategies and toxicity profiles for sarcomas |
| Larry E. Kun, MD (Dept. Chair) |
Improving diagnosis and therapy of brain tumors |
| Thomas E. Merchant, DO, PhD |
Treatment of CNS tumors and radiation-related CNS effects |
| Robert J. Ogg, PhD |
Imaging assessments of brain function in CNS and ocular tumors |
| Zoltán Patay, MD, PhD |
Brain tumor characterization by sophisticated quantitative MRI |
| Wilburn E. Reddick, PhD |
White matter injury in leukemia and CNS tumors |
| András Sablauer, MD, PhD |
Imaging informatics and computerized tumor modeling |
| Barry L. Shulkin, MD |
PET imaging and evaluation of pediatric tumors |
| Scott E. Snyder, PhD |
Design of radioactive diagnostic agents for functional medical imaging |
| Structural Biology |
| Donald E. Bashford, PhD |
Computational molecular biophysics |
| Eric Enemark, PhD |
Molecular mechanisms of DNA replication |
| Richard W. Kriwacki, PhD |
Structural basis of tumor suppressor function |
| Tanja Mittag, PhD |
Dynamic protein complexes in signal transduction |
| Junmin Peng, PhD |
Proteomics of ubiquitin biology and human disease |
| Brenda A. Schulman, PhD |
Cellular regulation by ubiquitin-like proteins |
| Stephen W. White, DPhil (Dept Chair) |
Structural analyses of catalysis and DNA repair |
| Jie Zheng, PhD |
Protein NMR and structure-based drug discovery |
| Surgery |
| Andrew M. Davidoff, MD (Dept Chair) |
Angiogenesis inhibition for cancer therapy |
| John A. Sandoval, MD |
Pediatric surgical oncology, novel therapies for solid tumors |
| Tumor Cell Biology |
| Linda M. Hendershot, PhD |
ER quality control in development and disease |
| Martine F. Roussel, PhD |
Genes and microRNAs in brain tumors |
| Charles J. Sherr, MD, PhD (Dept Chair) |
Tumor suppressor–dependent signaling networks |
 |